Cannabidiol Market Anticipates Growth as Regulatory Change Looms in U.S.

CannabisNewsWire Editorial Coverage: Restrictions in the United States on cannabidiol (CBD), an active ingredient in cannabis, appear likely to loosen over the next few months, creating opportunities for CBD production and distribution companies.

  • CBD is an active ingredient with medical benefits but no “high”, or pyshcoactive effects.
  • The Food and Drug Administration (FDA) has approved a CBD-based medicine for the first time.
  • Companies are cultivating hemp to develop high yielding CBD plants.

Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) is cultivating industrial hemp for CBD  propagation at sites in the United States and Canada while continuting to develop and manfuacture CBD-based products for its hempSMART™ brand. Cronos Group, Inc. (NASDAQ: CRON) is expanding its global reach for cannabis products through deals covering the United States, Canada, Australia and Poland, as this sector of the economy goes global. CV Sciences, Inc. (OTC: CVSI) is providing a clean bill of health for its CBD wellness products. Terra Tech Corp. (OTC: TRTC) is providing advanced hydroponic growing systems that increase crop yields and reduce costs for CBD-oriented companies. Manufacturer Liberty Health Sciences (OTC: LHSIF) produces cannabis in facilities recently certified as meeting high standards for manufacturing.

FDA Leads the Way to Reclassify Cannabidiol

The market for cannabis and hemp products has seen a low-key but potentially huge step forward in recent weeks. For the first time, the FDA has approved a medicine that uses cannabidiol (CBD) as its active ingredient. CBD is a compound that can be found in the hemp and cannabis plants, but unlike tetrahydrocannabinol (THC) it does not get users high.

Repeated studies have demonstrated the beneficial effects of cannabinoids. As a result, cannabis products have been approved for medical use in many states, but this is the first time that a cannabinoid-based CBD product has been approved at the federal level. This approval represents a softening of the federal government’s attitude. CBD was previously classified as a Schedule I drug by the Drug Enforcement Agency, but this body is now expected to change its stance within the next three months, allowing the possibility to manufacture products that would currently be banned on the national level. This possibility represents a huge moment for the CBD industry.

Better Plants for Better Health

One of the companies likely to benefit from this change is the Marijuana Company of America, Inc. (OTC: MCOA). The company is focused on the cultivation of industrial hemp and the manufacturing of hemp-derived CBD products, and is expanding its operations to better serve its growing market.

The most recent addition to the company’s operations is an industrial hemp cultivation site in Scio, Oregon. Created in collaboration with Global Hemp Group (GHG), this is a 109-acre site in the Willamette Valley. With its rich soil and pre-existing irrigation infrastructure, the valley provides an ideal location for an agricultural project that has already been home to cannabis cultivation in the past.

The Scio facility uses a mixture of cultivation practices. It has 19,000 square feet of greenhouse growing space under construction alongside fields for outdoor crops. This will allow the company to produce a steady supply of hemp all year, with high-yield plants ensuring a significant volume of output.

One of the main aims of the team working at Scio is to encourage plant strains that have a particularly high yield of CBD. Careful data collection and analysis are being used to assess the quality of plants and the effectiveness of techniques used to grow them. The expected change in the legal status of CBD in the United States will make it easier for MCOA to conduct research and cultivate CBD rich industrial hemp like at the Scio site, and for patients to have access to the products that come from it.

Working with Government to Improve Agriculture

MCOA and GHG are also collaborating on a similar project in New Brunswick, Canada, on a much larger scale. For this project, the two companies are working with the New Brunswick Department of Aquaculture, Agriculture and Fisheries (DAAF) to explore better approaches to growing hemp.

With markets for hemp and CBD reaching greater maturity, the DAAF has shown its faith in the future by awarding a grant of $10,750 to the joint MCOA and GHG venture in the region. These funds will be used on test projects for the current crop season, which will allow the companies to improve their cultivation techniques.

These government-funded tests are focused on three areas, two of which are looking at soil conditions to identify the best levels of nitrogen fertilizer for crops and whether soil acidity can be effectively adjusted using local supplies of slag lime. The third area of study is the European corn borer, a moth that damages crops and that has been a pest to farmers in the region. Damage from borers was found on hemp stalks last year, so the companies will be looking at the impact this damage could have on cultivation.

The latest technology is being used to ensure the success of these tests. A drone company has been employed to provide overviews of growth across hemp fields because the height of the stalks and density of cultivation makes assessment by other means difficult. With agricultural experiments underway in both Canada and the United States, MCOA has multiple opportunities to cultivate better CBD crops.

In New Brunswick, the two companies have created what they refer to as the Hemp Agro-Industrial Zone (HAIZ), where they are carrying out trials of hemp cultivation targeted at developing the industry in the province. By exploring cultivation techniques, ensuring a market for the product and providing consistent jobs for local farm workers, they aim to create a green-industry cluster specializing in hemp.

Creating Wellness

MCOA isn’t just a cultivation company. It is manufacturing its hemp crops into a wide range of products formulated to improve the well-being of customers.

Much of this work is carried out through hempSMART, the company’s most prominent consumer brand. HempSMART creates CBD-based wellness products and provides consumers with education about the potential benefits CBD may provide. Many consumers don’t understand the difference between CBD and THC products. Through hempSMART, MCOA is raising awareness while reaching out to a growing market.

The most recent release from hempSMART is the relaunch of its hempSMART Brain product. This version doubles the dose of CBD from the original, combining CBD oil with a blend of natural plant-based ingredients. Designed to maintain mental clarity, alertness, focus and concentration, as well as promote relaxation, restorative sleep, and the repair and regeneration of brain cells, hempSMART Brain is a flagship product that demonstrates MCOA’s wellness agenda. With the prospect of a change in the CBD compound’s legal status in the United States, companies such as MCOA will have more opportunities to develop and sell these types of products, spreading CBD-based wellness.

Growing Companies Profit from Changing Regulations

A range of companies in the cannabinoid sector will be in a position to profit from this change. Cronos Group, Inc. (NASDAQ: CRON) is demonstrating the global potential of cannabinoid products. The North American company already has a cross-border deal that allows it to make use of advances in both Canada and the United States. In addition, Cronos was recently granted a manufacturing license to produce cannabis-based products in Australia, and a new Polish distribution agreement will give the company a foothold in the European market.

CV Sciences, Inc. (OTC: CVSI) is firmly focused on the CBD sector. The company has two parts: a drug development division exploring novel CBD-based treatments and a consumer product division that manufactures, markets and sells the resulting products.

Some companies are focused on providing support and equipment for CBD cultivation. Terra Tech Corporation (OTC: TRTC) has created a hydroponic growing system that uses moving tables to increase yields by up to 30 percent while reducing costs by up to half. Its energy efficiency and recycling of waste water means that the company’s systems live up to the expectations of green-minded consumers.

Liberty Health Sciences (OTC: LHSIF) works in the medical cannabis market. As it acquires and operates U.S.-based cannabis companies, its aim is to produce safe, high-quality cannabis for patients. It has recently received Good Manufacturing Practice certification for its high standards of safety, consistency and quality.

Given the growing number of players in the cannabis market, a shift in the classification of CBD on a federal level could have a tremendous impact. For companies already focusing on CBD products, a huge opportunity for growth in the United States may be on the horizon.

For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC: MCOA)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Farm Bill Legislation May Springboard Federal Hemp Acceptance

CannabisNewsWire Editorial Coverage: The United States House passed the 2018 Farm Bill, which will redefine subsidies to farmers, nutritional welfare recipients, conservationists and others. Tucked into this bill of more than 1,000 pages is hemp legalization legislation supported by Senate Majority Leader Mitch McConnell. Demand – and thus farming revenue – for tobacco is waning, and McConnell says hemp farming could help bolster farming communities in his home state of Kentucky and across the country. Currently listed as a controlled substance under federal law, the new bill will declassify hemp as a schedule 1 drug and label it as a viable agricultural commodity. Through its hempSMART™ subsidiary, Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) is one example of a few companies currently providing consumers hemp plant-based products under the rubric of existing laws, and the company has undertaken broad-based legal hemp cultivation programs. Other companies that could feel the ripples of change in the space are Isodiol International, Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), CV Sciences, Inc. (OTC: CVSI), Medical Marijuana, Inc. (OTC: MJNA), and Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) (LXRP Profile).

Hemp’s History

Archaeological evidence reveals that for over 10,000 years hemp has been used by humans for pottery, shoes, ropes, clothing, food, medicine, and a wide array of other applications. Since early populations ingested hemp seeds, it stands to reason they also discovered the medicinal properties found in the plant. Ancient Asia, Egypt, India, Greece and the Islamic world all have rich histories relating to medicinal cannabis. In the 19th century, cannabinoids gained popularity for therapeutic use in Western medicine, but regulatory efforts imposed strictures during the 20th Century, eventually leading to a ban on its use in the U.S. under federal drug controls because of hemp’s relation to its more drug-user-friendly cannabis counterpart, marijuana. But, in recent years, society has turned to modern science to substantiate anecdotal claims about the therapeutic efficacy of non-psychoactive cannabidiol (CBD) found in the hemp plant.

“I know there are farming communities all over the country who are interested in this,” McConnell told the Senate Agriculture Committee amid debate over his bill. “Mine are particularly interested in it, and the reason for that is — as all of you know — our No. 1 cash crop used to be something that’s really not good for you: tobacco. And that has declined significantly, as it should, given the public health concerns.”

The federal government has exhibited schizophrenic regulatory tendencies toward hemp since the passage of the Marijuana Tax Act of 1937 that quashed hemp production with exorbitant excise taxes.  Reversing course during WWII, the government urged farmers to grow hemp for fiber and also waived taxes, and over 400,000 acres of hemp were cultivated between 1942 and 1945. After the war, hemp again had persona non grata status. Congress then passed the Controlled Substances Act in 1970, prohibiting the use of all cannabis for any purpose whatsoever and effectively terminating all industrial hemp production. Hemp extracts, however, are considered legal because they contain less than 0.3 percent THC, but the cultivation of hemp remains federally verboten. Now, the advancement of the Farm Bill signals a revived federal interest in the industrial hemp industry.

Hemp Pioneers

Led by hemp industry pioneers, Marijuana Company of America, Inc. (OTC: MCOA) has spearheaded efforts and staked claims on multiple legal hemp cultivation projects. The company’s innovative strategy is to vertically integrate hemp production and sales – from seed to shelf. Cultivation of quality hemp will feed MCOA’s innovative CBD-based formulations, which use the highest-quality hemp to produce what could be the finest-quality botanical supplements on the market. The hempSMART™ product line contains tested levels of clinically researched ingredients to meet consumer needs that support the body’s natural endocannabinoid system.

From seed to shelf, MCOA has built its business model around industrial hemp-based CBD products. Hemp has a myriad of uses beyond CBD therapeutics – as a food, a natural fiber, and even as a commodity in the building materials sectors. No part of the plant goes unused, and MCOA’s overarching strategy is to capitalize at each profit point – from farm to finished products. MCOA appears to be establishing a commanding presence at multiple inflection points across the entire hemp value chain.

hempSMART™, Inc.

Expanding on ancestral wisdom, MCOA has combined the most effective ingredients in wellness technologies with pure plant-derived industrial hemp-based cannabinoids to create optimally formulated wellness products for health-conscious consumers.

hempSMART™ offers a number of different products within a wide range of delivery systems, such as its capsule-based formulations hempSMART™ Brain, a patent-pending nootropic product designed to support natural brain function; and hempSMART™ Pain, which is formulated with a blend of premium full-spectrum CBD and botanical supplements designed for pain associated with physical activity.

The company also offers sublingual CBD tinctures to customers including hempSMART™ Full-Spectrum Drops and their natural pet supplement hempSMART™ Pet Drops with advanced bioavailability.

hempSMART™ has also expanded upon its established line of products by offering topical products such as hempSMART™ Pain Cream, which is designed to provide temporary relief and soothe sore, aching muscles and joints. The company also launched a new cosmetic product, hempSMART™ Face, a CBD facial moisturizer that has been designed to refresh, replenish and restore skin cells on the face.

MCOA’s hempSMART™ CBD consumer products are sold at www.hempsmart.com.

Hemp Cultivation

In what appears to be a vertically integrated business strategy, MCOA entered into a joint venture with Global Hemp Group Inc. (OTC: GBHPF) to launch multiple industrial hemp cultivation projects in the legal marijuana states of the U.S. and in Canada. The first is a 125-acre industrial hemp cultivation project in northeast New Brunswick. The project is well under way with objectives of promoting hemp farming and attendant year-round jobs.

A certified professional agronomist, Joan Parker-Duivenvoorden, has been hired to manage the project. She has over 15 years of experience with the Nova Scotia Department of Agriculture and with the New Brunswick Soil and Crop Improvement Association, which will prove invaluable as the project expands to encompass and employ over 50 farmers.

Planting has been completed on the first 77 acres, and the remaining 48 acres will be seeded soon. Drying equipment is being evaluated to process the hemp after harvest, and management is already in discussions with several potential processing partners for extraction of cannabinoids. Once all the licenses have been acquired for importing and manufacturing finished CBD products, the New Brunswick site could easily serve as a distribution center for MCOA’s hempSMART™ subsidiary.

In another joint venture with Global Hemp Group, MCOA is also developing Covered Bridge Acres, a high-yielding CBD hemp cultivation project in Oregon. Operations at the farm are well under way. The project will utilize both traditional outdoor cultivation and what will be over 19,296 square feet of greenhouses.

“Our evolving project in Scio, Oregon, highlights the quality of the team in place as they continue to lean on their many years of experience cultivating hemp. Activities such as these will help to secure the raw oil that we will need for our hempSMART brand of CBD infused products,” stated Donald Steinberg, MCOA’s CEO.

The Takeaway

With rapidly expanding retail distribution and burgeoning, diversified hemp cultivation programs underway, MCOA is fast approaching the vertical integration that typically impacts bottom lines and drives shareholder value.

Other companies already operating in the CBD space include:

Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) grows and harvests hemp on an industrial scale and then processes it to extract cannabidiol (CBD) for worldwide distribution. The company pioneered the commercialization of 99 percent-plus pure, pharmaceutical-grade cannabinoids, micro-encapsulations and nanotechnology for consumable and topical skin care products.

CV Sciences (OTC: CVSI) operates in two business segments. The company’s drug development division develops and commercializes novel therapeutics utilizing synthetic CBD. Its consumer product division manufactures, markets and sells plant-based CBD products to a range of market sectors.

Medical Marijuana (OTC: MJNA) develops, distributes and sells hemp oil that contains naturally occurring cannabinoids, including CBD, and other products containing CBD oil. The company sells its hemp-derived CBD products through its distribution subsidiaries. The company was among the first to bring hemp-based CBD oil products to market in the United States.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) out-licenses its patented delivery technology, which lowers dosing of lipophilic active molecules and enhances their effectiveness. The company’s technology increases intestinal absorption rates, speeds delivery to the bloodstream, and masks tastes for orally administered bioactive molecules including cannabinoids, vitamins, NSAIDs, nicotine and other molecules.

Together, MCOA and these companies weave a tapestry of industry, innovation and intuitive concern for the communities they serve with nature-based hemp products that appear to be once again losing the stigma that has come from being marijuana’s staider sibling.

For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC: MCOA)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Dangers Lurking in Synthetic CBD Underscore Value of Quality Product

CannabisNewsWire Editorial Coverage: Dating back thousands of years, people have found ways to treat pain and other ailments with cannabidiol (CBD) oil which is harvested from the hemp plant. However, the natural healing properties of CBD are being jeopardized by the advent of man-made synthetic CBDs. These chemical analogs are dangerous imitations of plant-derived product, binding to human endocannabinoid receptors at astronomically larger quantities than natural cannabinoids. These designer drugs prompted the U.S. Centers for Disease Control and Prevention to issue a national health alert warning about synthetic cannabinoids. Shunning synthetics, Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) provides consumers complete transparency and delivering only pure, plant-based 100% hemp-derived products through its hempSMART™ brand. While Medical Marijuana, Inc. (OTC: MJNA) and PotNetwork Holding, Inc. (OTC: POTN) market hemp-derived CBD products, some companies such as Isodiol International, Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) and CV Sciences, Inc. (OTC: CVSI) utilize extraction techniques to produce isolated cannabinoid compounds for both commercial and/or research uses.

Surging Demand Creates Copy Cats

Hemp-derived CBD grew from a market category that didn’t exist five years ago to generating $190 million in sales in 2017. The U.S. industry is poised to reach $1 billion dollars in 2018, led by hemp-derived CBD, food, personal care and industrial products. Hemp Business Journal estimates the U.S. hemp industry will grow to a $2.6 billion market by 2022 with an estimated five-year CAGR of 25%.

In a recent article, “Fighting fakes: Hemp leaders on the dangers of synthetic CBD,” public health investigators issued warnings when 50 people were sickened after consuming synthetic CBD. What the epidemiologists found was that the products, while labeled CBD, did not contain CBD compounds. Instead, the products contained a synthetically produced cannabinoid.

CBD products are often mislabeled, both in how much CBD the products contain and where the CBD comes from. A study published in JAMA revealed that nearly 70% of online CBD marijuana extracts are mislabeled, some had extra CBD, some less, and some contained hidden CBDs. Blind testing found that only about 31% of the extracts tested contained the amount of CBD listed on the label.

Differentiated from Others

The company’s commitment to quality may differentiate Marijuana Company of America, Inc. (OTC:MCOA) from all others in the sector. MCOA uses the highest-quality sourced raw materials to produce the finest quality botanical supplements and topicals on the market. To ensure quality and transparency, the company’s hempSMART™ product line has been rigorously tested to validate its purity. Products developed by hempSMART are derived and formulated from industrial hemp containing naturally occurring CBD compounds that help support the body’s natural endocannabinoid system. All hempSMART™ products contain tested levels and clinically researched ingredients designed to meet and exceed consumers expectations.

The company is led by cannabis industry pioneer Donald Steinberg, MCOA’s CEO and an experienced veteran of the cannabis and industrial hemp industries. Steinberg founded the first marijuana company ever to trade on a U.S. stock market, and his extensive background and knowledge of the industry may give the company unparalleled insights into the global industrial hemp and cannabis markets.

Celebrated Family of Products

Derived from industrial hemp containing CBD compounds, MCOA’s hempSMART™ product line is among the finest quality of botanical supplements on the market. Scientifically driven, each of MCOA’s hempSMART™ products are created to ensure only the highest quality products reach discerning consumers. MCOA’s hempSMART™ CBD consumer products are researched, developed and sold at www.hempsmart.com.

The company recently re-launched its patent-pending wellness nootropic product hempSMART™ Brain, a “first of its kind” researched formulation for optimal brain function support, with 300mg of full spectrum CBD per bottle. HempSMART products also include full spectrum bioavailable CBD drops in form of a tincture containing a high concentration and potency of CBD, hempSMART ™ Pain capsules with a blend of premium CBD and botanical supplements, and hempSMART ™ Pain Cream with a synergistic combination of natural botanicals and full spectrum hemp extract to treat aching muscles and joints. In addition, the company now provides hempSMART™ Full Spectrum Pet Drops, exclusively designed for fur-bearing family members.

To virally expand sales, MCOA created its own unique hempSMART affiliate network marketing program. The affiliate marketing program provides a generous compensation plan to promote and sell hempSMART’s CBD consumer products in the United States. Advocates of hempSMART’s CBD products make the best ambassadors and the sales model lends itself to rapid global expansion.

Diversified Opportunity

In addition to the research and development of hemp-based consumer products, MCOA is strategically expanding its footprint across multiple facets of the hemp industry, building a portfolio of diversified investments and joint ventures to grow the company and potentially drive shareholder value.

The company recently provided updates on its 125-acre industrial hemp cultivation project in northeast New Brunswick with joint-venture partner Global Hemp Group Inc. (OTC: GBHPF). Planting on the first 77 acres is complete and the remaining 48 acres will be seeded soon. Drying equipment is being evaluated to process the biomass after harvest and management is in discussions with several potential processing partners for the material.

To target impulse buys in high traffic convenience stores, MCOA secured a 25% equity stake in Convenient Hemp Mart, LLC’s BeniHemp branded products. BeniHemp products will include topicals, tinctures, and edibles packaged in one-day, two-day, and 30-day supplies distributed to convenience stores, smoke shops, gas stations and similar small retail businesses.

Each owning 42.5%, MCOA and Global Hemp Group formed a joint venture, Covered Bridge Acres LTD., to develop a high yielding CBD hemp cultivation project in Oregon and committed to jointly invest a total of US$1.2 million into the project. A cornerstone of the project is the acquisition of a 109-acre agricultural property in Scio, Oregon. The property, located 70 miles south of Portland, is situated in the fertile Willamette Valley and has a history of hemp cultivation over the past two years. The farm is ideal for cultivating hemp as it contains a high level of organic matter in the soil and has an established irrigation infrastructure with sufficient water rights.

MCOA successfully raised $1 million in funding for Bougainville Ventures to construct and manage a turnkey state of the art cannabis cultivation and processing facility. The joint venture has completed the setup of 10,000 sq. ft. of greenhouse space and waiting for completion of inspection, the final step before commencing cultivation.

Active Companies Vying for Market Position

CV Sciences (OTCQB: CVSI) operates two business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing naturally occurring CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company recently announced the June 7, 2018, publication of the toxicology and safety results of an extract from the base raw materials used in its PlusCBD Oil™ consumer products. The study, designed to investigate the safety of oral consumption of the company’s hemp CBD oil and to support a Generally Recognized as Safe (GRAS) Independent Conclusion, concluded that the test article was non-mutagenic, non-clastogenic and non-genotoxic.

Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) is focused on pharmaceutical grade phytochemical compounds and is among industry leaders in the manufacture and development of consumer products. The company pioneered the commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for consumable and topical skin care products. Isodiol earlier this month entered into a binding agreement to acquire 51% of Round Mountain Technologies, LLC (“RMT”), a cultivator of organic hemp with operations in Nevada.

Medical Marijuana (OTC: MJNA), the first publicly traded cannabis company in the United States (founded by current CEO of Marijuana Company of America Don Steinberg), develops, distribute and sells hemp oil that contains naturally occurring cannabinoids, including CBD and other products containing CBD oil. In recent news, MJNA announced its favor on the Drug Enforcement Administration’s (DEA) recent statement on the legality of CBD — which further clarifies that some CBD products, such as hemp-derived CBD products, are legal to distribute throughout the United States and do not fall under the regulations of the Controlled Substances Act (CSA). Additionally, the company’s HempMeds® subsidiary reported the historic authorization of its Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil product for import into Argentina.

PotNetwork Holding (OTC: POTN) is a holding company for its subsidiaries, First Capital Venture Co. that owns Diamond CBD, Inc., the maker of Diamond CBD oils. Diamond CBD researches, develops and markets hemp extracts that contain a broad range of cannabinoids and hemp derivatives. The company recently announced that Diamond CBD’s online sales increased 639% higher than the year prior. PotNetwork is in currently preparing to file with the SEC to become a fully reporting company.

With an estimated 25% compound annual growth rate, there’s little doubt the about the trajectory of the CBD market. As the market continues its rapid expansion and more people become aware of the dangers lurking in synthetic CBD, it seems reasonable that evermore consumers will gravitate toward high-quality natural CBD product. Companies like MCOA aim to answer that call.

For more information on Marijuana Company of America, visit Marijuana Company of America, Inc. (OTC: MCOA)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

CBD Market Set for Huge Growth

CannabisNewsWire Editorial Coverage: In a fragile economic world, industries with significant growth forecast are certain to catch the eye of savvy investors looking for just the right place to be. Recent reports indicate that the cannabidiol (CBD) market is estimated to grow by 700 percent by 2020, and a report by market intelligence firm Hemp Business Journal projects that the CBD market will grow to $2.1 billion by 2020 (http://cnw.fm/7iczS), an astronomical jump in value compared to last year’s CBD market of $202 million. This news bodes well for hemp-focused companies such as Marijuana Company of America (OTC: MCOA) (MCOA Profile), whose hempSMART™ brand will be among the first CBD products to be marketed on a mass national TV commercial. Growth in hemp-based products is only a piece of the cannabis industry puzzle. The entire legal cannabis industry is expected to hit $57 billion by 2027, with recreational marijuana use making up 67 percent of that and medical marijuana use taking up the remaining 33 percent. Other companies positioning themselves to take advantage of this incredible growth include AbbVie, Inc. (NYSE: ABBV), CV Sciences, Inc. (OTCQB: CVSI), KushCo Holdings, Inc. (OTCQB: KSHB), and Aurora Cannabis, Inc (OTCQX: ACBFF).

Capitalizing on the Power of CBD

Studies show that cannabidiol (CBD) possesses an array of therapeutic benefits, including antioxidant and neuroprotective properties. One of more than 85 cannabinoids identified in marijuana and hemp, CBD is typically used for health reasons and, unlike the more widely recognized compound tetrahydrocannabinol (THC), is not psychoactive, meaning it doesn’t cause a high. CBD products can be derived from industrial hemp plants or marijuana plants.

Marijuana Company of America (MCOA Profile), an industrial hemp company, has capitalized on the power of CBD through its product research and development of legal hemp-based consumer products under the hempSMART brand, which targets general health and well-being. The products, which include drops and creams, are formulated to produce the finest botanical supplements on the market, derived from industrial hemp containing CBD compounds that help support the bodies endocannabinoid system.

A National Market Strategy and TV Commercial

 Earlier this month, MCOA announced (http://cnw.fm/WxIg1) that it had engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television ad campaign to promote its hempSMART product line. Initially, hempSMART will be working with Verve Integrative to develop a market strategy and television commercial for its hempSMART Full Spectrum Pet Drops, which will air on cable networks this summer. The commercial spot will have featured placement on the official ecommerce site of a popular direct-response TV company and will be broadly promoted on integrated social media outlets.

“We are very pleased to partner with hempSMART on their journey to bring such thoughtful and well-developed products to the people who need natural relief and enhanced health solutions. I wish hempSMART™ Pet Drops were available to support my cherished dog when we were going through a health challenge together,” said Castle, who, along with her team, bring more than 25 years of experience in many variations of media strategy, development and production. Their clients include Disney, GM, ABC, Paramount, and Grey Group.

The team specializes in multipoint story experiences designed to educate, entertain and endorse while mirroring the human mind’s process of solving a problem, thereby supporting consumers in making emotional and logical product conclusions. Castle’s experience provides an invaluable edge to the hempSMART marketing campaign. Castle has also been an outspoken advocate of CBD as an alternative to traditional products currently on the market.

MCOA CEO Donald Steinberg noted that “Kim’s experience gives us an excellent opportunity to greatly expand the marketing strategy for the hempSMART brand and product line. We are honored that the hempSMART product line will be managed by her and the Verve Integrative team. We look forward to the new television commercial airing this summer.”

Pet Supplement Market Expanding

MCOA just launched its hempSMART Full Spectrum Pet Drops in February. The new specially formulated product contains naturally occurring CBD derived from hemp seed oil, full spectrum hemp extract, and fractionated coconut oil, along with a rich bacon flavor.

Sales of natural pet supplement sales nearly doubled between 2008 and 2011, and with an increasing focus on pet health, the market for pet supplements is projected to show significant and continuing expansion (http://cnw.fm/66NhV). Estimates show that U.S. retail sales of pet supplements and nutraceutical treats will grow 3 to 5 percent annually, bringing the market to almost $1.6 billion. Globally, the pet supplement market is also expected to experience tremendous growth.

Steinberg said, “Our new hempSMART product is a natural option for pet owners who care about supporting their animals’ healthy energy levels as well as optimizing their health. Our hempSMART product line will continue to expand to other popular areas of consumer interest to give our affiliates what they need to succeed.”

Wellness Environment Shifting toward CBD

The wellness industry is growing rapidly, generating an estimated $3.72 trillion annually (http://cnw.fm/d3Zs5). In addition, the attitude in the wellness environment is shifting regarding premium quality cannabinoid products. MCOA is one of the prominent companies working to give consumers access to technological innovations and the highest quality hemp-derived products.

Specifically designed to support normal bodily functions such as energy, flexibility, and overall wellness, hempSMART products are only the beginning for MCOA and its hempSMART division. MCOA is committed to find, test, and deliver the finest natural ingredients focused on wellness and personal care combined with the added benefits of hemp-based cannabinoids.

In addition to dedicating itself to the development of CBD-based nutritional products, MCOA is focused on educating and empowering consumers to learn about and become part of the hemp movement, thus allowing its customers to benefit from some of the world’s most innovative hemp products. The company is also dedicated to supporting the resurgence of green sustainable hemp-based products and technologies that have a positive effect on the environment.

Others Positioning in the Market

MCOA isn’t the only company deeply committed to making its presence felt in the burgeoning hemp and cannabis industries.

AbbVie (NASDAQ: ABBV) is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. With a cannabis-based drug already available on the market, pharmaceutical company AbbVie, is ahead of the pack in this industry. Its FDA-approved Marinol is approved for chemotherapy-induced nausea and vomiting and anorexia, and the drug may also help AIDS patients who have lost their desire to eat.

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD, and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The company’s PlusCBD Oil™ has achieved immense success since the launch of its brand of dietary supplements. The brand is currently being sold in approximately 1,300 health food stores and continues to grow its shelf presence in various retail outlets across the country. “It’s evident that hemp-derived CBD products are doing better and growing faster than almost every other category in the supplement industry, and it’s been a long time since we’ve seen a supplement trend truly demonstrate demand in such an immense fashion,” said Stuart Tomc, vice president of human nutrition and spokesperson for CV Sciences. “There are no barriers to acceptance as the idea of hemp-derived CBD is finally ripe. Consumers are embracing hemp-derived CBD.”

The premier packaging company in the rapidly growing legal, regulated marijuana industry, KushCo Holdings, Inc. (OTCQB: KSHB) is a dynamic sales and distribution platform that provides packaging, supplies, vaporizer products, hydrocarbons, accessories, and branding services to cannabis manufacturers, processors and retailers. Founded in 2010, Kush Bottles now has 12 facilities throughout the United States, a sales presence in every major cannabis market, and strives to be the go-to supplier and thought leader for businesses in the cannabis industry. KushCo recently announced that it had partnered with MainStem, a technology-based ancillary product distribution company for the regulated cannabis industry, to be the inaugural partner for MainStem’s Vendor Program (MVP).

An industry leading producer of medical cannabis, Aurora Cannabis, Inc (OTCQX: ACBFF) operates a 55,200-square-foot, state-of-the-art production facility in Mountain View County, Alberta, and a second 40,000-square-foot, high-technology production facility in Pointe-Claire, Quebec. In January 2018, Aurora’s 800,000 square-foot-flagship cultivation facility located at the Edmonton International Airport was licensed. When at full capacity, this facility is expected to produce over 100,000 kg per annum of cannabis. Aurora is also completing a facility in Lachute. In addition, the company just announced its intention to acquire MedReleaf Corp. (TSX: LEAF). This proposed transaction will bring together two of Canada’s premier cannabis companies with fully aligned strategic visions and production philosophies, as well as complementary assets, distribution networks, products, and capabilities. The combined company will meet what Aurora and MedReleaf management teams consider to be the critical success factors in the industry, creating a powerful platform for accelerated growth on a global scale.

For more information about Marijuana Company of America, please visit Marijuana Company of America (MCOA).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.